Literature DB >> 33252657

Parallels Between the Antiviral State and the Irradiated State.

Heather M McGee1, Ariel E Marciscano2, Allison M Campbell3, Arta M Monjazeb4, Susan M Kaech1, John R Teijaro5.   

Abstract

Improved understanding of host antiviral defense and antitumor immunity have elucidated molecular pathways important to both processes. During viral infection, RNA or DNA in the host cell serves as a danger signal that initiates the antiviral response. Recent studies have elucidated similarities in the signaling pathways activated by viruses and the signaling pathways induced by tumor DNA that is released into the cytoplasm of irradiated tumor cells. Both the host defense to viral infection and the sterile inflammation provoked by radiotherapy induce a type I interferon response that is necessary for pathogen control and immune-mediated tumor control, respectively. These findings have led to the hypothesis that radiotherapy employs a form of viral mimicry.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33252657      PMCID: PMC8502484          DOI: 10.1093/jnci/djaa190

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  103 in total

1.  Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA.

Authors:  Gregory M Barton; Jonathan C Kagan; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2005-12-11       Impact factor: 25.606

2.  Flt3-ligand administration after radiation therapy prolongs survival in a murine model of metastatic lung cancer.

Authors:  P K Chakravarty; A Alfieri; E K Thomas; V Beri; K E Tanaka; B Vikram; C Guha
Journal:  Cancer Res       Date:  1999-12-15       Impact factor: 12.701

Review 3.  Crosstalk pathways between Toll-like receptors and the complement system.

Authors:  George Hajishengallis; John D Lambris
Journal:  Trends Immunol       Date:  2010-02-10       Impact factor: 16.687

4.  Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity.

Authors:  Leticia Corrales; Laura Hix Glickman; Sarah M McWhirter; David B Kanne; Kelsey E Sivick; George E Katibah; Seng-Ryong Woo; Edward Lemmens; Tamara Banda; Justin J Leong; Ken Metchette; Thomas W Dubensky; Thomas F Gajewski
Journal:  Cell Rep       Date:  2015-05-07       Impact factor: 9.423

5.  Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.

Authors:  P Lindahl; I Gresser; P Leary; M Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

6.  Type I interferon is selectively required by dendritic cells for immune rejection of tumors.

Authors:  Mark S Diamond; Michelle Kinder; Hirokazu Matsushita; Mona Mashayekhi; Gavin P Dunn; Jessica M Archambault; Hsiaoju Lee; Cora D Arthur; J Michael White; Ulrich Kalinke; Kenneth M Murphy; Robert D Schreiber
Journal:  J Exp Med       Date:  2011-09-19       Impact factor: 14.307

Review 7.  Radiation-Induced Chromosomal Aberrations and Immunotherapy: Micronuclei, Cytosolic DNA, and Interferon-Production Pathway.

Authors:  Marco Durante; Silvia C Formenti
Journal:  Front Oncol       Date:  2018-05-29       Impact factor: 6.244

8.  TOX is a critical regulator of tumour-specific T cell differentiation.

Authors:  Andrew C Scott; Friederike Dündar; Paul Zumbo; Smita S Chandran; Christopher A Klebanoff; Mojdeh Shakiba; Prerak Trivedi; Laura Menocal; Heather Appleby; Steven Camara; Dmitriy Zamarin; Tyler Walther; Alexandra Snyder; Matthew R Femia; Elizabeth A Comen; Hannah Y Wen; Matthew D Hellmann; Niroshana Anandasabapathy; Yong Liu; Nasser K Altorki; Peter Lauer; Olivier Levy; Michael S Glickman; Jonathan Kaye; Doron Betel; Mary Philip; Andrea Schietinger
Journal:  Nature       Date:  2019-06-17       Impact factor: 49.962

9.  Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death.

Authors:  Encouse B Golden; Derek Frances; Ilenia Pellicciotta; Sandra Demaria; Mary Helen Barcellos-Hoff; Silvia C Formenti
Journal:  Oncoimmunology       Date:  2014-04-25       Impact factor: 8.110

10.  Cancer therapies activate RIG-I-like receptor pathway through endogenous non-coding RNAs.

Authors:  Diana Rose E Ranoa; Akash D Parekh; Sean P Pitroda; Xiaona Huang; Thomas Darga; Anthony C Wong; Lei Huang; Jorge Andrade; Jonathan P Staley; Takashi Satoh; Shizuo Akira; Ralph R Weichselbaum; Nikolai N Khodarev
Journal:  Oncotarget       Date:  2016-05-03
View more
  1 in total

Review 1.  Regulation of the Cell-Intrinsic DNA Damage Response by the Innate Immune Machinery.

Authors:  Thomas J Hayman; Peter M Glazer
Journal:  Int J Mol Sci       Date:  2021-11-25       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.